Health & Biotech Investment Banking Pitch Decks

Browse 517 presentations in Health & Biotech. Search by topic, industry, or year.

I'm feeling lucky

49–96 of 517 presentationsPage 2 of 11

$Ada Health — ada \inside investment banking deck cover$

Ada Health — ada \inside

2018

Ada Health · Health & Biotech

28 slides

Ada Health — Meet Ada Health investment banking deck cover

Ada Health — Meet Ada Health

2021

Ada Health · Health & Biotech

11 slides

Adagio Therapeutics investment banking deck cover

Adagio Therapeutics

2021

Adagio Therapeutics · Health & Biotech

42 slides

Adagio Therapeutics — Corporate Overview investment banking deck cover

Adagio Therapeutics — Corporate Overview

2023

Adagio Therapeutics · Health & Biotech

18 slides

Adagio Therapeutics — Corporate Overview investment banking deck cover

Adagio Therapeutics — Corporate Overview

2023

Adagio Therapeutics · Health & Biotech

17 slides

Adagio Therapeutics — Corporate Presentation investment banking deck cover

Adagio Therapeutics — Corporate Presentation

2022

Adagio Therapeutics · Health & Biotech

27 slides

Adagio Therapeutics — Corporate Presentation December 2022 investment banking deck cover

Adagio Therapeutics — Corporate Presentation December 2022

Adagio Therapeutics · Health & Biotech

27 slides

Adagio Therapeutics — Cover Slide investment banking deck cover

Adagio Therapeutics — Cover Slide

2022

Adagio Therapeutics · Health & Biotech

19 slides

Adagio Therapeutics — Investor Presentation September 2022 investment banking deck cover

Adagio Therapeutics — Investor Presentation September 2022

Adagio Therapeutics · Health & Biotech

27 slides

Adagio Therapeutics — J.P. Morgan 41st Annual Healthcare Conference investment banking deck cover

Adagio Therapeutics — J.P. Morgan 41st Annual Healthcare Conference

2023

Adagio Therapeutics · Health & Biotech

10 slides

Adagio Therapeutics — Jefferies Healthcare Conference investment banking deck cover

Adagio Therapeutics — Jefferies Healthcare Conference

2023

Adagio Therapeutics · Health & Biotech

11 slides

Adagio Therapeutics — Results from the Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Adintrevimab (ADG20) in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP) investment banking deck cover

Adagio Therapeutics — Results from the Phase 2/3 Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Adintrevimab (ADG20) in the Treatment of Ambulatory Participants with Mild or Moderate COVID-19 (STAMP)

2022

Adagio Therapeutics · Health & Biotech

4 slides

Aeglea Biotherapeutics — 1 Year Data from First in Human Study of Pegzilarginase for the Treatment of Arginase 1 Deficiency (ARG1-D) investment banking deck cover

Aeglea Biotherapeutics — 1 Year Data from First in Human Study of Pegzilarginase for the Treatment of Arginase 1 Deficiency (ARG1-D)

Aeglea Biotherapeutics · Health & Biotech

13 slides

Aeglea Biotherapeutics — Corporate Overview investment banking deck cover

Aeglea Biotherapeutics — Corporate Overview

2023

Aeglea Biotherapeutics · Health & Biotech

56 slides

Aeglea Biotherapeutics — Corporate Overview investment banking deck cover

Aeglea Biotherapeutics — Corporate Overview

2023

Aeglea Biotherapeutics · Health & Biotech

38 slides

Aeglea Biotherapeutics — Corporate Overview investment banking deck cover

Aeglea Biotherapeutics — Corporate Overview

2023

Aeglea Biotherapeutics · Health & Biotech

56 slides

Aeglea Biotherapeutics — Corporate Overview investment banking deck cover

Aeglea Biotherapeutics — Corporate Overview

2023

Aeglea Biotherapeutics · Health & Biotech

37 slides

Aeglea Biotherapeutics — KOL Webinar on Classical Homocystinuria and Pegtarviliase investment banking deck cover

Aeglea Biotherapeutics — KOL Webinar on Classical Homocystinuria and Pegtarviliase

2022

Aeglea Biotherapeutics · Health & Biotech

28 slides

Aeglea Biotherapeutics — Reimagining The Potential Of Human Enzyme Therapeutics investment banking deck cover

Aeglea Biotherapeutics — Reimagining The Potential Of Human Enzyme Therapeutics

2020

Aeglea Biotherapeutics · Health & Biotech

28 slides

Aeglea Biotherapeutics — Reimagining The Potential Of Human Enzyme Therapeutics investment banking deck cover

Aeglea Biotherapeutics — Reimagining The Potential Of Human Enzyme Therapeutics

2021

Aeglea Biotherapeutics · Health & Biotech

23 slides

Aeglea Biotherapeutics — Reimagining The Potential Of Human Enzyme Therapeutics investment banking deck cover

Aeglea Biotherapeutics — Reimagining The Potential Of Human Enzyme Therapeutics

2020

Aeglea Biotherapeutics · Health & Biotech

22 slides

Aeglea Biotherapeutics — Transaction & Overview investment banking deck cover

Aeglea Biotherapeutics — Transaction & Overview

2023

Aeglea Biotherapeutics · Health & Biotech

50 slides

Akouos — Title Slide investment banking deck cover

Akouos — Title Slide

2020

Akouos · Health & Biotech

48 slides

Albireo Pharma — ASSERT Topline Data Results investment banking deck cover

Albireo Pharma — ASSERT Topline Data Results

2022

Albireo Pharma · Health & Biotech

18 slides

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy investment banking deck cover

Aldeyra Therapeutics — Top-Line Results from Part 1 of the Phase 3 GUARD Trial of ADX-2191 in Proliferative Vitreoretinopathy

2022

Aldeyra Therapeutics · Health & Biotech

13 slides

Alkermes — A Clear Investment Thesis investment banking deck cover

Alkermes — A Clear Investment Thesis

2023

Alkermes · Health & Biotech

28 slides

Alkermes — Alkermes 2024: Profitable, Pure-play Neuroscience Company investment banking deck cover

Alkermes — Alkermes 2024: Profitable, Pure-play Neuroscience Company

2024

Alkermes · Health & Biotech

28 slides

Alkermes — Alkermes: A Clear Investment Thesis investment banking deck cover

Alkermes — Alkermes: A Clear Investment Thesis

2023

Alkermes · Health & Biotech

32 slides

Alkermes — Alkermes: Advancing Key Business Priorities in 2022 investment banking deck cover

Alkermes — Alkermes: Advancing Key Business Priorities in 2022

2022

Alkermes · Health & Biotech

36 slides

Alkermes — Mural Oncology Investor Call investment banking deck cover

Alkermes — Mural Oncology Investor Call

2023

Alkermes · Health & Biotech

37 slides

Alkermes — Nemvaleukin Alfa: A Novel, Engineered Interleukin-2 (IL-2) Variant Immunotherapy investment banking deck cover

Alkermes — Nemvaleukin Alfa: A Novel, Engineered Interleukin-2 (IL-2) Variant Immunotherapy

2022

Alkermes · Health & Biotech

26 slides

Allarity Therapeutics — Personalized Cancer Care Realized investment banking deck cover

Allarity Therapeutics — Personalized Cancer Care Realized

2022

Allarity Therapeutics · Health & Biotech

23 slides

Allscripts Healthcare Solutions — Investor Day investment banking deck cover

Allscripts Healthcare Solutions — Investor Day

2022

Allscripts Healthcare Solutions · Health & Biotech

57 slides

Allurion investment banking deck cover

Allurion

Allurion · Health & Biotech

25 slides

American Oncology Network — Investor Presentation investment banking deck cover

American Oncology Network — Investor Presentation

2022

American Oncology Network · Health & Biotech

26 slides

An2 Therapeutics — Cover Slide investment banking deck cover

An2 Therapeutics — Cover Slide

An2 Therapeutics · Health & Biotech

27 slides

An2 Therapeutics — Cover Slide investment banking deck cover

An2 Therapeutics — Cover Slide

An2 Therapeutics · Health & Biotech

25 slides

Anebulo Pharmaceuticals — Title Slide investment banking deck cover

Anebulo Pharmaceuticals — Title Slide

2022

Anebulo Pharmaceuticals · Health & Biotech

52 slides

Angiodynamics investment banking deck cover

Angiodynamics

Angiodynamics · Health & Biotech

11 slides

Apexigen — Corporate Overview investment banking deck cover

Apexigen — Corporate Overview

2022

Apexigen · Health & Biotech

27 slides

Apexigen — Title Slide investment banking deck cover

Apexigen — Title Slide

2022

Apexigen · Health & Biotech

27 slides

Argenx Se — Reaching Patients through Immunology Innovation investment banking deck cover

Argenx Se — Reaching Patients through Immunology Innovation

Argenx Se · Health & Biotech

10 slides

Atai — Cognitive Impairment Associated with Schizophrenia – a KOL webinar investment banking deck cover

Atai — Cognitive Impairment Associated with Schizophrenia – a KOL webinar

2022

Atai · Health & Biotech

42 slides

Atai — Cover Slide investment banking deck cover

Atai — Cover Slide

2022

Atai · Health & Biotech

36 slides

Atai — Cover Slide investment banking deck cover

Atai — Cover Slide

2022

Atai · Health & Biotech

49 slides

Atai — Cover Slide investment banking deck cover

Atai — Cover Slide

2024

Atai · Health & Biotech

34 slides

Atai — Cover Slide investment banking deck cover

Atai — Cover Slide

2022

Atai · Health & Biotech

41 slides

Atai — Title Slide investment banking deck cover

Atai — Title Slide

2023

Atai · Health & Biotech

31 slides